Physician profile
Jonathon Gurule
NPI 1285262899
$10,261.97
in general payments reported to CMS, 2019-2025
8 companies · $1,424 in 2025
The $1,424 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,742 · 2023: $752 · 2024: $1,343 · 2025: $1,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,519.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $6,236.81 | 2022-2024 | |
| Stryker Corporation | $3,136.67 | 2022-2025 | Gamma, Augment Injectable, Mako |
| Depuy Synthes Sales INC. | $316.49 | 2024 | Na, Fibergraft Aeridyan Matrix, Lcp |
| Prodigy Surgical Distribution, INC. | $307.76 | 2025 | |
| Cerapedics INC. | $168.02 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Polynovo North America LLC | $36.95 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $33.44 | 2022 | |
| Ethicon US, LLC | $25.83 | 2024 | Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Gurule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.